Samsara Therapeutics
samsaratherapeutics.com
Actively hiring
Biotechnology
Health Care
Neurology & CNS Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$10.3M
1 round on record
Latest round
$10.3M
Venture round · Jul 2021 · 5 yr ago
Team
11-50
employees, estimated range
The money's age
Long since its last round
62 months since the last round · not hiring
Momentum
0/100
no fresh signals
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Jul 2021 | $10.3M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Samsara Therapeutics Inc. | sec |
Founders and leadersfrom filings, registers and the company's site
Jens EcksteinExecutive Officer, DirectorSEC Form D
Similar startupsby what they do, their industry and backers
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Brenig Therapeutics develops innovative small-molecule therapies for neurodegenerative diseases, including LRRK2 inhibitors targeting…
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Boldly advancing the next generation of medicines for Alzheimer’s Disease and Related Dementias.
Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular…
What's AltPep?. We are a group of innovators working to transform the diagnosis and treatment of amyloid diseases, enabling action earlier…
Overview
We are on a mission to unlock the full potential of autophagy activation in combating age-related neurodegenerative diseases.
People
Jens Eckstein
Executive Officer, Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Lewes
United States
HQ
10-50 est. staff
Financials
Total raised
$10.3M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2021 | $10.3M | Details |